Melinda Brown insider trades
Open-market stock purchases and sales by Melinda Brown, Director at Precision Biosciences Inc, from SEC Form 4 filings since Nov 4, 2016.
Track record: 100% of 5 scored buys are up 5% or more since purchase, averaging +40%.